Infantile Hemiplegia
Conditions
Keywords
infantile hemiplegia, upper extremity, physical therapy
Brief summary
This is a comparative study where two protocols of intensive therapies will be applied to study the improvements in the functional performance of the affected upper limb of children with hemiparesis and check whether to increase their quality of life.
Detailed description
the intervention protocols combine different doses of intensive therapy, being 80 hours of modified constraint induced movement therapy followed by 20 hours for protocol 1 and protocol 2 would be the application of protocol 1 inverted, with this, the investigators want to compare how both protocols interfere in the function of the affected upper limb of children with different levels of bimanual functional performance.
Interventions
COMBINATION_PRODUCTintensive therapies(CIMT/BIT): protocol 1 or protocol 2
The therapies applied in both protocols are intensive therapies that allow the execution of unimanual activities or bimanual activities with the affected upper limb with different doses. the protocols were carried out at home through the family
Sponsors
University of Salamanca
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
5 Years to 10 Years
Healthy volunteers
No
Inclusion criteria
* Children diagnosed with Unilateral Infantile Cerebral Palsy, Congenital Infantile Hemiparesis. * Ages between 5 to 10 years. * Levels of I-III within the , manual ability classification system, MACS. * Levels of I-III within the gross motor function classification system, GMFCS
Exclusion criteria
\- Diseases not associated with infantile hemiparesis. * Low cognitive level to understand the execution of activities. * Surgeries of the upper extremity during the 6 months prior to the intervention. * Structured contractures in the affected upper extremity that cause functional impotence. * Botulinum toxin two months prior to the intervention and application of it during the treatment. * Epilepsy not controlled pharmacologically
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| bimanual functional performance, change is being assessed | 4 assessments will be carried out in the research in 10 weeks | use of the affected upper extremity of spontaneous character during bimanual activities. It is used the AHA assessment to measure it. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| quality of life ,change is being assessed | 4 assessments will be carried out in the research in 10 weeks | This measure will be assessed with the pedsQL questionnaire |
Countries
Spain
Outcome results
None listed